|
|
|
Insider
Information: |
Clancy Paul J |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
138,295 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$20,757,220 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
138,295 |
|
|
Total
Value |
$20,757,220 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biogen Idec Inc |
BIIB |
Executive VP and CFO |
2017-04-25 |
10,813 |
|
0 |
Premium* |
|
Alexion Pharmaceuticals Inc |
ALXN |
EVP, Chief Financial O... |
2019-07-11 |
90,447 |
2017-07-10 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2024-03-28 |
15,785 |
2019-03-29 |
0 |
Premium* |
|
Agios Pharmaceuticals Inc |
AGIO |
Director |
2022-05-20 |
6,549 |
2019-05-31 |
0 |
Premium* |
|
Exact Sciences Corp |
EXAS |
Director |
2023-06-08 |
14,701 |
2021-03-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
119 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2008-08-08 |
4 |
AS |
$50.66 |
$28,777 |
D/D |
(568) |
42,669 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2016-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
579 |
27,143 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
CFO |
|
2008-02-12 |
4 |
D |
$60.56 |
$44,936 |
D/D |
(742) |
31,131 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
CFO |
|
2008-02-12 |
4/A |
D |
$60.56 |
$44,936 |
D/D |
(742) |
31,131 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2010-08-01 |
4 |
D |
$55.88 |
$46,660 |
D/D |
(835) |
46,897 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2011-08-01 |
4 |
D |
$102.90 |
$85,922 |
D/D |
(835) |
41,412 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2013-02-08 |
4 |
D |
$164.44 |
$147,832 |
D/D |
(899) |
25,478 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
CFO |
|
2008-06-01 |
4 |
D |
$62.75 |
$59,801 |
D/D |
(953) |
41,710 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
CFO |
|
2008-02-12 |
4 |
AS |
$60.76 |
$58,397 |
D/D |
(958) |
30,173 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
CFO |
|
2008-02-12 |
4/A |
AS |
$60.76 |
$58,397 |
D/D |
(958) |
45,863 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
CFO |
|
2008-02-17 |
4 |
D |
$62.20 |
$63,257 |
D/D |
(1,017) |
44,846 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2014-02-08 |
4 |
D |
$315.54 |
$330,370 |
D/D |
(1,047) |
9,231 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2016-02-08 |
4 |
D |
$250.77 |
$262,556 |
D/D |
(1,047) |
24,404 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Financial Officer |
|
2019-02-28 |
4 |
D |
$132.93 |
$143,431 |
D/D |
(1,079) |
86,249 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2008-09-04 |
4 |
D |
$48.16 |
$53,650 |
D/D |
(1,114) |
41,555 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2009-09-04 |
4 |
D |
$51.01 |
$56,825 |
D/D |
(1,114) |
43,591 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2010-09-04 |
4 |
D |
$56.24 |
$62,651 |
D/D |
(1,114) |
45,783 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2011-02-23 |
4 |
D |
$66.76 |
$74,704 |
D/D |
(1,119) |
46,499 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2015-02-08 |
4 |
D |
$402.00 |
$459,486 |
D/D |
(1,143) |
17,503 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2009-08-01 |
4 |
D |
$47.55 |
$56,252 |
D/D |
(1,183) |
44,705 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2009-06-01 |
4 |
D |
$50.90 |
$63,778 |
D/D |
(1,253) |
45,888 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2010-06-01 |
4 |
D |
$47.22 |
$59,167 |
D/D |
(1,253) |
47,732 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2020-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,282 |
4,026 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2014-02-12 |
4 |
D |
$323.04 |
$427,705 |
D/D |
(1,324) |
13,193 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2019-05-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,400 |
1,400 |
0 |
- |
|
119 Records found
|
|
Page 2 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|